Osaic Holdings
PYXS icon

Osaic Holdings’s Pyxis Oncology PYXS Stock Holding History

Osaic Holdings’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20K Sell
13,721
-3,503
-20% -$5.28K ﹤0.01% 5858
2025
Q4 		$19.8K Buy
17,224
+2,003
+13% +$7.07K ﹤0.01% 5893
2025
Q3 		$19.5K Sell
15,221
-2,500
-14% -$3.6K ﹤0.01% 5943
2025
Q2 		$19.5K Sell
17,721
-4,658
-21% -$5.25K ﹤0.01% 5727
2025
Q1 		$21.9K Hold
22,379
– – ﹤0.01% 5297
2024
Q4 		$34.9K Buy
22,379
+16,558
+284% +$47.8K ﹤0.01% 4955
2024
Q3 		$21.4K Buy
5,821
+1,450
+33% +$5.07K ﹤0.01% 5351
2024
Q2 		$14.5K Buy
4,371
+1,250
+40% +$5.25K ﹤0.01% 5550
2024
Q1 		$13.3K Buy
3,121
+485
+18% +$2.04K ﹤0.01% 5591
2023
Q4 		$4.74K Sell
2,636
-5,150
-66% -$8.82K ﹤0.01% 6202
2023
Q3 		$15.5K Hold
7,786
– – ﹤0.01% 5687
2023
Q2 		$19.9K Sell
7,786
-214
-3% -$679 ﹤0.01% 5570
2023
Q1 		$32.1K Buy
+8,000
New +$16K ﹤0.01% 5276

Other funds holding PYXS

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GGI
GordonMD Global Investments Beverely Hills, California $144M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Osaic Holdings's PYXS Position: Q1 2026 in Review

Osaic Holdings reduced its Pyxis Oncology (PYXS) stake by 20% in Q1 2026, selling an estimated $5.28K and leaving 13,721 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #5858.

Osaic Holdings first reported a position in PYXS in Q1 2023 and has held it in 13 quarters since. The position peaked at $34.9K in Q4 2024. 78 funds tracked by Wall St. Rank hold PYXS as of Q1 2026.

  • Osaic Holdings held 13,721 shares of Pyxis Oncology worth $20K as of Q1 2026.
  • Osaic Holdings sold 3,503 Pyxis Oncology shares in Q1 2026, an estimated $5.28K.
  • Pyxis Oncology made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #5858 holding.
  • Osaic Holdings first reported a position in Pyxis Oncology in Q1 2023 and has held it in 13 quarters since.
  • Osaic Holdings's Pyxis Oncology position peaked at $34.9K in Q4 2024.
  • 78 funds tracked by Wall St. Rank held Pyxis Oncology as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.